A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
The global market for Continuous Glucose Monitoring Systems was estimated to be worth US$ 4612 million in 2023 and is forecast to a readjusted size of US$ 17360 million by 2030 with a CAGR of 20.6% during the forecast period 2024-2030
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Continuous Glucose Monitoring Systems by region & country, by Type, and by End Users.
The Continuous Glucose Monitoring Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring Systems.
Market Segmentation
By Company
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Segment by Type:
Wearable
Implantable
Segment by End Users
Child
Adult
Elderly
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End Users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Continuous Glucose Monitoring Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Continuous Glucose Monitoring Systems in country level. It provides sigmate data by Type, and by End Users for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Continuous Glucose Monitoring Systems Product Introduction
1.2 Global Continuous Glucose Monitoring Systems Market Size Forecast
1.2.1 Global Continuous Glucose Monitoring Systems Sales Value (2019-2030)
1.2.2 Global Continuous Glucose Monitoring Systems Sales Volume (2019-2030)
1.2.3 Global Continuous Glucose Monitoring Systems Sales Price (2019-2030)
1.3 Continuous Glucose Monitoring Systems Market Trends & Drivers
1.3.1 Continuous Glucose Monitoring Systems Industry Trends
1.3.2 Continuous Glucose Monitoring Systems Market Drivers & Opportunity
1.3.3 Continuous Glucose Monitoring Systems Market Challenges
1.3.4 Continuous Glucose Monitoring Systems Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Continuous Glucose Monitoring Systems Players Revenue Ranking (2023)
2.2 Global Continuous Glucose Monitoring Systems Revenue by Company (2019-2024)
2.3 Global Continuous Glucose Monitoring Systems Players Sales Volume Ranking (2023)
2.4 Global Continuous Glucose Monitoring Systems Sales Volume by Company Players (2019-2024)
2.5 Global Continuous Glucose Monitoring Systems Average Price by Company (2019-2024)
2.6 Key Manufacturers Continuous Glucose Monitoring Systems Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Continuous Glucose Monitoring Systems Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Continuous Glucose Monitoring Systems
2.9 Continuous Glucose Monitoring Systems Market Competitive Analysis
2.9.1 Continuous Glucose Monitoring Systems Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Continuous Glucose Monitoring Systems Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring Systems as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Wearable
3.1.2 Implantable
3.2 Global Continuous Glucose Monitoring Systems Sales Value by Type
3.2.1 Global Continuous Glucose Monitoring Systems Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Continuous Glucose Monitoring Systems Sales Value, by Type (2019-2030)
3.2.3 Global Continuous Glucose Monitoring Systems Sales Value, by Type (%) (2019-2030)
3.3 Global Continuous Glucose Monitoring Systems Sales Volume by Type
3.3.1 Global Continuous Glucose Monitoring Systems Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Continuous Glucose Monitoring Systems Sales Volume, by Type (2019-2030)
3.3.3 Global Continuous Glucose Monitoring Systems Sales Volume, by Type (%) (2019-2030)
3.4 Global Continuous Glucose Monitoring Systems Average Price by Type (2019-2030)
4 Segmentation by End Users
4.1 Introduction by End Users
4.1.1 Child
4.1.2 Adult
4.1.3 Elderly
4.2 Global Continuous Glucose Monitoring Systems Sales Value by End Users
4.2.1 Global Continuous Glucose Monitoring Systems Sales Value by End Users (2019 VS 2023 VS 2030)
4.2.2 Global Continuous Glucose Monitoring Systems Sales Value, by End Users (2019-2030)
4.2.3 Global Continuous Glucose Monitoring Systems Sales Value, by End Users (%) (2019-2030)
4.3 Global Continuous Glucose Monitoring Systems Sales Volume by End Users
4.3.1 Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2019 VS 2023 VS 2030)
4.3.2 Global Continuous Glucose Monitoring Systems Sales Volume, by End Users (2019-2030)
4.3.3 Global Continuous Glucose Monitoring Systems Sales Volume, by End Users (%) (2019-2030)
4.4 Global Continuous Glucose Monitoring Systems Average Price by End Users (2019-2030)
5 Segmentation by Region
5.1 Global Continuous Glucose Monitoring Systems Sales Value by Region
5.1.1 Global Continuous Glucose Monitoring Systems Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Continuous Glucose Monitoring Systems Sales Value by Region (2019-2024)
5.1.3 Global Continuous Glucose Monitoring Systems Sales Value by Region (2025-2030)
5.1.4 Global Continuous Glucose Monitoring Systems Sales Value by Region (%), (2019-2030)
5.2 Global Continuous Glucose Monitoring Systems Sales Volume by Region
5.2.1 Global Continuous Glucose Monitoring Systems Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Continuous Glucose Monitoring Systems Sales Volume by Region (2019-2024)
5.2.3 Global Continuous Glucose Monitoring Systems Sales Volume by Region (2025-2030)
5.2.4 Global Continuous Glucose Monitoring Systems Sales Volume by Region (%), (2019-2030)
5.3 Global Continuous Glucose Monitoring Systems Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Continuous Glucose Monitoring Systems Sales Value, 2019-2030
5.4.2 North America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Continuous Glucose Monitoring Systems Sales Value, 2019-2030
5.5.2 Europe Continuous Glucose Monitoring Systems Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Continuous Glucose Monitoring Systems Sales Value, 2019-2030
5.6.2 Asia Pacific Continuous Glucose Monitoring Systems Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Continuous Glucose Monitoring Systems Sales Value, 2019-2030
5.7.2 South America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Continuous Glucose Monitoring Systems Sales Value, 2019-2030
5.8.2 Middle East & Africa Continuous Glucose Monitoring Systems Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value
6.2.1 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value, 2019-2030
6.2.2 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Continuous Glucose Monitoring Systems Sales Value, 2019-2030
6.3.2 United States Continuous Glucose Monitoring Systems Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Continuous Glucose Monitoring Systems Sales Value by End Users, 2023 VS 2030
6.4 Europe
6.4.1 Europe Continuous Glucose Monitoring Systems Sales Value, 2019-2030
6.4.2 Europe Continuous Glucose Monitoring Systems Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Continuous Glucose Monitoring Systems Sales Value by End Users, 2023 VS 2030
6.5 China
6.5.1 China Continuous Glucose Monitoring Systems Sales Value, 2019-2030
6.5.2 China Continuous Glucose Monitoring Systems Sales Value by Type (%), 2023 VS 2030
6.5.3 China Continuous Glucose Monitoring Systems Sales Value by End Users, 2023 VS 2030
6.6 Japan
6.6.1 Japan Continuous Glucose Monitoring Systems Sales Value, 2019-2030
6.6.2 Japan Continuous Glucose Monitoring Systems Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Continuous Glucose Monitoring Systems Sales Value by End Users, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Continuous Glucose Monitoring Systems Sales Value, 2019-2030
6.7.2 South Korea Continuous Glucose Monitoring Systems Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Continuous Glucose Monitoring Systems Sales Value by End Users, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Continuous Glucose Monitoring Systems Sales Value, 2019-2030
6.8.2 Southeast Asia Continuous Glucose Monitoring Systems Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Continuous Glucose Monitoring Systems Sales Value by End Users, 2023 VS 2030
6.9 India
6.9.1 India Continuous Glucose Monitoring Systems Sales Value, 2019-2030
6.9.2 India Continuous Glucose Monitoring Systems Sales Value by Type (%), 2023 VS 2030
6.9.3 India Continuous Glucose Monitoring Systems Sales Value by End Users, 2023 VS 2030
7 Company Profiles
7.1 Dexcom
7.1.1 Dexcom Company Information
7.1.2 Dexcom Introduction and Business Overview
7.1.3 Dexcom Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Dexcom Continuous Glucose Monitoring Systems Product Offerings
7.1.5 Dexcom Recent Development
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Information
7.2.2 Abbott Laboratories Introduction and Business Overview
7.2.3 Abbott Laboratories Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Laboratories Continuous Glucose Monitoring Systems Product Offerings
7.2.5 Abbott Laboratories Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Medtronic Continuous Glucose Monitoring Systems Product Offerings
7.3.5 Medtronic Recent Development
7.4 Senseonics Holdings
7.4.1 Senseonics Holdings Company Information
7.4.2 Senseonics Holdings Introduction and Business Overview
7.4.3 Senseonics Holdings Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Senseonics Holdings Continuous Glucose Monitoring Systems Product Offerings
7.4.5 Senseonics Holdings Recent Development
7.5 GlySens Incorporated
7.5.1 GlySens Incorporated Company Information
7.5.2 GlySens Incorporated Introduction and Business Overview
7.5.3 GlySens Incorporated Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2019-2024)
7.5.4 GlySens Incorporated Continuous Glucose Monitoring Systems Product Offerings
7.5.5 GlySens Incorporated Recent Development
7.6 Meiqi Medical Equipment
7.6.1 Meiqi Medical Equipment Company Information
7.6.2 Meiqi Medical Equipment Introduction and Business Overview
7.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Meiqi Medical Equipment Continuous Glucose Monitoring Systems Product Offerings
7.6.5 Meiqi Medical Equipment Recent Development
7.7 San Meditech
7.7.1 San Meditech Company Information
7.7.2 San Meditech Introduction and Business Overview
7.7.3 San Meditech Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2019-2024)
7.7.4 San Meditech Continuous Glucose Monitoring Systems Product Offerings
7.7.5 San Meditech Recent Development
8 Industry Chain Analysis
8.1 Continuous Glucose Monitoring Systems Industrial Chain
8.2 Continuous Glucose Monitoring Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Continuous Glucose Monitoring Systems Sales Model
8.5.2 Sales Channel
8.5.3 Continuous Glucose Monitoring Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
听
听
*If Applicable.
